Norgestrel
Overview
Norgestrel is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107797).
API suppliers (6)
Suppliers of Norgestrel evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 6 suppliers.
2 of 6 hold a GMP certificate on record in the EU or UK registers
- Gedeon Richter Usa2 active DMF
- Bayer PlcUnited Kingdom1 active DMF
- Lupin LimitedIndia1 active DMF GMP on record
- STERLING SPAItaly1 active DMF GMP on record
- Hunan KYF Pharmaceutical. Co., LtdChina1 active DMF
- SCINOPHARM TAIWAN LTDTaiwan
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Norgestrel expires — and exclusivity 13 Jul 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (8R,9S,10R,13S,14S)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- Canonical SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34
- InChIKey
- WWYNJERNGUHSAO-CULCCENASA-N
Do you supply Norgestrel? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.